• Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

    One year ago - By News Medical

    Intersect ENT, Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a pooled analysis in the International Forum of Allergy & Rhinology, the official journal of the American Rhinologic Society, of the company's PROPEL Contour and PROPEL Mini steroid-releasing sinus implants showing improved outcomes of frontal sinus surgery.
    Read more ...